INTRODUCTION
Myotonic muscular dystrophy (MyD)' is a systemic genetic disorder inherited as an autosomal dominant trait. It is characterized by variable penetrance and expression (1) . The involvement of multiple organ systems has led to a suspicion that the disease results from a generalized defect in cellular membrane function (2, 3) . This hypothesis has been supported by observations in muscle from MyD patients indicating a decreased membrane protein phosphorylation associated with no differences in protein content or other membrane marker enzymes (4) . Erythrocytes from Receiued for publication 28 November 197.9 and in revised form 14 February 1980. 1 Abbreviations used in this paper: HEDTA, N-hydroxyethylenediaminetriacetic acid; MyD, myotoinic muscuilar dystrophy; TMA-Cl, tetramethylammonium chloride.
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MyD patients show an altered [32P]phosphorylation of membrane band 3, an altered stoichiometry of the sodium-potassium pump and differences in membrane properties measured by electron spin resonance spectroscopy (2, (5) (6) (7) (8) . When erythrocytes from MyD patients are depleted of ATP by exposure to iodoacetic acid and adenosine (9, 10) , a diminished calcium-induced potassium efflux is observed. Because the plasma membrane of MyD erythrocytes has an enhanced permeability to calcium (11) , this diminished effectiveness of calcium is paradoxical and provided the impetus for our current studies.
This study exaimines the relative magnitudes and calcium sen sitivities of calcium-iniduced potassiumn leak and calcium-induced phosphatidic acid acctumulation, a measure of phosphoinositide phosphodiesterase activity in inorm-ial ATP-replete erythrocytes (12) . A uniform impairmnent in calcium-sensitive phosphatidic acid accumutlation has been observed in erythrocytes obtained fromii \IyD patients.
METHODS
Erythrocytes from MyD patients and from sex-, age-matched healthy individuals were obtained by antecubital venipuncture into heparinized (10 U/ml) syringes and placed on ice. Both patient and control samples were obtained at the same time and tested in identical fashion. For incubation, the blood was washed as described previously (13, 14) to remove plasma, buffy coat, and microclots. All incubations were at 20°C in a gently shaking water bath (American Optical Corp., Scientific Instrument Div., Buffalo, N. Y.) for 1-2 h. The erythrocytes vere suspended in either isotonic or hypertonici solutions of tetramethylammonium chloride (TMA-Cl) containing 0 or 40 mM CaCl2 (13, 14) . In HEDTA to produce different ratios of Ca HEDTA to HEDTA. The total concentration of HEDTA was maintained at 1 mM. The ionic calcium concentrations were calculated using an apparent pK' of 6.1 for pH 7.80 (15) Cells were prepared for calcium determination by an initial 1:2 dilution of erythrocyte suspension with 300 mosmol/kg TMA-Cl solution containing 10 mM ethylene glycol bis (2 amino ethylether) tetraacetate, pH 7. After centrifugation the cells were resuspended in a 300-mosmol/kg TMA-Cl solution containing 5 mM ethylenediaminetetraacetate, pH 7, and then washed five times with a 300-mosmol/kg TMA-Cl solution containing 5 mM Tris, pH 7.4. Calcium measurements were made with a model 403 atomic spectrophotometer (Perkin-Elmer Corp., Instrument Div., Norwalk, Conn.) equipped with a heated graphite atomizer (16) . Potassium concentrations were measured on an Instrumentation Laboratory, Inc., Lexington, Mass. flame photometer. Hemoglobin content was determined by a semiautomated modification of the cyanmethhemoglobin procedure (17) . ATP was measured by an automated luciferinluciferase technique (18) .
Erythrocyte lipids were extracted in chloroform/methanol/2 M KCl (1:1:0.5) with a 0.005% butylated hydroxytoluene (12, 19) . The lower phase was evaporated under reduced pressure and resuspended in a small volume of chloroform for separation on silica gel H, 0.001 M Na2CO3 impregnated, thin-layer chromatography plates (Analtech, Inc., Newark, Del.) (20, 21 times from the silica gel with chloroform/methanol/acetic acid (1:1:0.12) (19) . These extracts were pooled, filtered, and evaporated under reduced pressure, then resuspended in 1 ml cyclohexane with 0.005% butylated hydroxytoluene immediately before analysis. Phosphatidic acid contents of these extracts were determined by a semiautomated modification of a rhodamine-G fluorescence assay (22). Recovery values for phosphatidic acid added to erythrocytes before extraction range from 90 to 96%. Fig. 1 In control erythrocytes, calcium entry leads to the accumulation of phosphatidic acid by hydrolysis of phosphatidylinositol phosphate to diacylglycerol (23) which, in ATP-replete erythrocytes, is further metabolized to phosphatidic acid (24). Because ATP is required for the conversion of diacylglycerol to phosphatidic acid, it was possible that the lack of phosphatidic acid accumulation was related to an excessive loss of ATP in erythrocytes from patients with MyD. We examined this possibility by measuring the ATP contents of control and MyD erythrocytes during both types of calcium loading procedures. The results displayed in Fig. 3 show that the ATP levels ofboth control and MyD cells were similar throughout all experimental protocols.
RESULTS

DISCUSSION
These data show that intact erythrocytes from MyD patients have an impairment of phosphatidic acid accumulations in response to calcium exposure. We believe these observations are notable in two respects: (a) the difference between MyD and control data appears to be more marked than in any other abnormality heretofore described in this disorder; (b) the impairment of phosphatidic acid accumulation is evident in patients with mild as well as severe clinical involvement. Hence, it is possible that affected individuals may be discriminated by these measurements. We would caution, however, that we do not know whether the impairment in calcium-induced phosphatidic acid There is no difference in ATP levels between control and MyD erythrocytes in any of these incubation conditions. O, control subjects; El, MyD patients. tl = 4 and 5, respectively. accumulation is unique for MyD nor, as yet, have we elucidated the specific metabolic alterations in phospholipid metabolism that account for this defect. Further work on the specificity and pathogenesis of the biochemical alteration is in progress.
Several possible mechanisms for impaired phosphatidic acid accumulation in response to calcium can be excluded. A decreased calcium uptake in MyD erythrocytes could not be demonstrated in a previous study (11) or in experiments presented in Fig. 1 . An explanation involving the excessive loss ofATP in MyD erythrocytes with a consequent inability to produce phosphatidic acid can be excluded on the basis of data in Fig. 3 , that show similar contents of ATP in control and MyD erythrocytes. An explanation based upon an altered distribution of calcium within MyD erythrocytes seems unlikely in view of the normal calcium sensitivity of the potassium leak observed under our incubation conditions. Furthermore, phosphatidic acid accumulation is impaired in the absence (Fig. 1) as well as the presence (Fig. 2) of calcium ionophore A23187. Because we performed the ionophore experiments in the presence of ionic calcium buffers, an explanation based on the lack of availability of calcium at an intracellular site seems unlikely.
Mechanisms that we cannot evaluate by current data involve alterations in phospholipid metabolism in plasma membrane. These possibilities include: (a) Reduced membrane content ofphosphatidylinositol phosphate, the substrate for the calcium-sensitive phosphodiesterase (23). We believe this to be an unlikely possibility on the basis of a previous observation which showed no differences between control and MyD erythrocytes in the incorporation of 32P from [y-32p] ATP into phosphatidylinositol phosphate.2 (b) A decrease in the amount or calcium sensitivity of the calcium-sensitive phosphodiesterase enzyme. (c) A reduction of diacylglycerol kinase activity necessary for the conversion of diacylglycerol to phosphatidic acid. Additional experimental data will be necessary to decide among these possibilities as well as to determine the relationship of these data to altered band 3 phosphorylation (2, (4) (5) (6) or the other disturbances in membrane function that have been previously described in this disorder (7) (8) (9) (10) (11) .
